These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 17852158)
1. Multivitamins and phospholipids complex protects the hepatic cells from androgenic-anabolic-steroids-induced toxicity. Pagonis TA; Koukoulis GN; Hadjichristodoulou CS; Toli PN; Angelopoulos NV Clin Toxicol (Phila); 2008 Jan; 46(1):57-66. PubMed ID: 17852158 [TBL] [Abstract][Full Text] [Related]
2. Psychiatric side effects induced by supraphysiological doses of combinations of anabolic steroids correlate to the severity of abuse. Pagonis TA; Angelopoulos NV; Koukoulis GN; Hadjichristodoulou CS Eur Psychiatry; 2006 Dec; 21(8):551-62. PubMed ID: 16356691 [TBL] [Abstract][Full Text] [Related]
3. Body composition, cardiovascular risk factors and liver function in long-term androgenic-anabolic steroids using bodybuilders three months after drug withdrawal. Hartgens F; Kuipers H; Wijnen JA; Keizer HA Int J Sports Med; 1996 Aug; 17(6):429-33. PubMed ID: 8884417 [TBL] [Abstract][Full Text] [Related]
4. Effects of androgenic-anabolic steroids in athletes. Hartgens F; Kuipers H Sports Med; 2004; 34(8):513-54. PubMed ID: 15248788 [TBL] [Abstract][Full Text] [Related]
5. Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions. Nieschlag E; Vorona E Rev Endocr Metab Disord; 2015 Sep; 16(3):199-211. PubMed ID: 26373946 [TBL] [Abstract][Full Text] [Related]
6. Hepatotoxicity associated with illicit use of anabolic androgenic steroids in doping. Solimini R; Rotolo MC; Mastrobattista L; Mortali C; Minutillo A; Pichini S; Pacifici R; Palmi I Eur Rev Med Pharmacol Sci; 2017 Mar; 21(1 Suppl):7-16. PubMed ID: 28379599 [TBL] [Abstract][Full Text] [Related]
7. Recreational Anabolic-Androgenic Steroid Use Associated With Liver Injuries Among Brazilian Young Men. Schwingel PA; Cotrim HP; Santos CR; Santos AO; Andrade AR; Carruego MV; Zoppi CC Subst Use Misuse; 2015; 50(11):1490-8. PubMed ID: 26549387 [TBL] [Abstract][Full Text] [Related]
8. Left ventricular early myocardial dysfunction after chronic misuse of anabolic androgenic steroids: a Doppler myocardial and strain imaging analysis. D'Andrea A; Caso P; Salerno G; Scarafile R; De Corato G; Mita C; Di Salvo G; Severino S; Cuomo S; Liccardo B; Esposito N; Calabrò R Br J Sports Med; 2007 Mar; 41(3):149-55. PubMed ID: 17178777 [TBL] [Abstract][Full Text] [Related]
10. Anabolic androgenic steroid-induced hepatotoxicity. Bond P; Llewellyn W; Van Mol P Med Hypotheses; 2016 Aug; 93():150-3. PubMed ID: 27372877 [TBL] [Abstract][Full Text] [Related]
11. Telephone counseling of athletes abusing anabolic-androgenic steroids. Takahashi M; Tatsugi T; Kohno Y J Sports Med Phys Fitness; 2007 Sep; 47(3):356-60. PubMed ID: 17641605 [TBL] [Abstract][Full Text] [Related]
12. Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem. Melnik B; Jansen T; Grabbe S J Dtsch Dermatol Ges; 2007 Feb; 5(2):110-7. PubMed ID: 17274777 [TBL] [Abstract][Full Text] [Related]
13. Reversibility of the effects on blood cells, lipids, liver function and hormones in former anabolic-androgenic steroid abusers. Urhausen A; Torsten A; Wilfried K J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):369-75. PubMed ID: 12711025 [TBL] [Abstract][Full Text] [Related]
14. A retrospective 30-year follow-up study of former Swedish-elite male athletes in power sports with a past anabolic androgenic steroids use: a focus on mental health. Lindqvist AS; Moberg T; Eriksson BO; Ehrnborg C; Rosén T; Fahlke C Br J Sports Med; 2013 Oct; 47(15):965-9. PubMed ID: 23613517 [TBL] [Abstract][Full Text] [Related]
15. Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study. Rasmussen JJ; Selmer C; Østergren PB; Pedersen KB; Schou M; Gustafsson F; Faber J; Juul A; Kistorp C PLoS One; 2016; 11(8):e0161208. PubMed ID: 27532478 [TBL] [Abstract][Full Text] [Related]
16. Anabolic-androgenic steroids: a possible new risk factor of toxicant-associated fatty liver disease. Schwingel PA; Cotrim HP; Salles BR; Almeida CE; dos Santos CR; Nachef B; Andrade AR; Zoppi CC Liver Int; 2011 Mar; 31(3):348-53. PubMed ID: 21040407 [TBL] [Abstract][Full Text] [Related]
17. Short QT interval is unreliable marker of anabolic androgenic steroid abuse in competitive athletes. Djordjević V; Stanković I; Stipac AV; Putniković B; Nesković AN Srp Arh Celok Lek; 2012; 140(11-12):711-6. PubMed ID: 23350243 [TBL] [Abstract][Full Text] [Related]
18. [Hepatoprotective effects of silymarin in androgenic-anabolic steroid-induced liver damage]. Radovanović D; Jovanović D; Mihailović D; Ranković G; Stojiljković N; Dimitrov V Med Pregl; 2003; 56 Suppl 1():79-83. PubMed ID: 15510919 [TBL] [Abstract][Full Text] [Related]
19. Concomitant abuse of anabolic androgenic steroids and human chorionic gonadotrophin impairs spermatogenesis in power athletes. Karila T; Hovatta O; Seppälä T Int J Sports Med; 2004 May; 25(4):257-63. PubMed ID: 15162244 [TBL] [Abstract][Full Text] [Related]
20. [Anabolic androgenic steroids in amateur sports in the Netherlands]. Woerdeman J; de Hon O; Levi M; de Ronde WP Ned Tijdschr Geneeskd; 2010; 154():A2004. PubMed ID: 20858322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]